Alloy Secures $3.3 mln In Seed Funding To Develop Health Platform For Women Over 40

Alloy a New York-based telehealth startup, has raised $3.3 million in seed funding to expand its platform, which addresses health concerns for women over 40.

With participation from venture studio Kairos HQ and PACE Healthcare Capital, the capital raised in the round will be used to strengthen the startup’s network, grow its staff, and boost community engagement ahead of the launch of the platform later this year. Alex Fiance, Kairos Co-Founder and Co-CEO, said about the firm’s participation in the round:

“Kairos’ mission is to build businesses that tackle pressing challenges and create common sense solutions. We are blown away by how difficult the healthcare experience is for women 40+, which is why we have been working alongside Alloy for the last 18 months to create a solution. We are honored to collaborate with Anne, Monica and Dr. Sharon Malone as they transform the way that millions of women experience aging.”

Founded earlier this year with the mission to empower women over 40, Allow is offering science-based solutions to the problems that can arise when menopause starts. The startup is achieving this by offering telehealth, prescription, and community services via its platform, a holistic approach that has proven especially beneficial Anne Fulenwider, Alloy Co-Founder and Co-CEO, referred to this mission by stating:

“We are fiercely dedicated to rewriting the aging narrative for women, and making sure they’re informed on all the options available to help them to feel like their best selves. Alloy exists because too many women haven’t been able to get the treatment they need. We are here to course correct post-reproductive healthcare and we could not be more excited to share this platform with the world.”

The transition from perimenopause to menopause has always been troublesome for medical practitioners, who more often than not fail to recognize the more than 34 symptoms associated with it. The lack of a consistent age, the biological and psychological difference between women, the wide number of symptoms, and just a straight lack of information make menopause a natural stage in a woman’s life that often results in anxiety as a result of a lack of proper management.

With menopause increasing the risk of heart disease, stroke, and osteoporosis, as well as a decrease in work productivity, the implications of failing to manage the symptoms are severe. According to a study by Stanford University, the estimated cost of menopausal symptoms can result in over $367million when it comes to additional healthcare and lost work. By creating a platform specialized in the management of menopause, Allow has the potential to address a multi-million problem while, most importantly, improving the quality of life of millions of women in the United States.